CardioVations Announces Next in Line of Innovative Heart Stabilization Systems; Device Gives Surgeons Precision and Control during Heart Bypass Surgery.
This new device builds on the innovative standards set by the predecessor device, FLEXSITE* Heart Stabilizer. The new EMBRACE stabilizer provides surgeons extreme confidence for the most demanding off-pump coronary artery bypass (OPCAB) procedures, with a 360-degree rotation and tilt for optimal visualization and access to lateral wall vessels. The malleable foot pods allow for custom contouring to the epicardial surface and the low-profile suction pods gently spread tissue at the anastomotic site. The redesigned low-profile stabilizer arm provides for quick, one-step stabilization and control with a unique activation lever. This simple, single-hand activation lever provides control to fine-tune adjustments and positioning.
"For patients undergoing coronary revascularization, off-pump surgery has been shown to be beneficial," stated Valavanur Subramanian, MD, Director, Department of Surgery, Lenox Hill Hospital, New York, NY. "Devices such as the EMBRACE stabilizer allow for complete revascularization during an off-pump procedure and are valuable additions to the ongoing development of beating heart surgery."
It is estimated that the "off-pump" method of coronary bypass is used in 25% of all coronary bypass surgeries.(1) Allowing the patient's own lungs and heart to maintain circulation rather than artificial components has been shown to be beneficial to patients.
The surgeon should not position the stabilizer foot pods over a coronary artery, or over newly infarcted or aneurysmal heart tissue. Physicians should be adequately trained and have familiarity with less invasive cardiac surgical procedures. They should consult medical literature relative to techniques, complications, and hazards prior to performance of any cardiac surgical procedure. Many variables, including patient anatomy, pathology and surgical techniques may influence procedural outcomes. As with any surgical procedure, there are risks associated with heart surgery using these devices. Risks associated with this procedure are typical of those associated with conventional coronary artery surgery.
CardioVations, a division of ETHICON, INC., a Johnson & Johnson Company, is a pioneer in cardiovascular surgery devices that reduce complications and improve outcomes for patients. CardioVations offers innovations in the areas of off-pump coronary artery bypass grafting (CABG), valve surgery, anastomotic devices and vessel management. Additional information on CardioVations can be found at http://www.cardiovations.com/.
* Trademark (1) Medtech Insight, Novel Connections in Bypass Surgery, May 2002. Contact: Amy Firsching 908-218-2783 email@example.com
CONTACT: Amy Firsching, +1-908-218-2783, firstname.lastname@example.org
Web site: http://www.cardiovations.com/
|Printer friendly Cite/link Email Feedback|
|Date:||Apr 20, 2004|
|Previous Article:||Stepan Announces First Quarter Earnings Conference Call and Webcast.|
|Next Article:||30% Discount on 1st Class One-Way Thalys Tickets for Summer Travel Between France-Belgium-Netherlands-Germany.|